Facebook Twitter LinkedIn Instagram Email Printer Google Plus


Three CEOs discuss why digital treatments are on the cusp of becoming mainstream and share their five-year outlooks.

Partner, Health and Life Sciences, Oliver Wyman
Executive Chairman, President and CEO, Click Therapeutics
Former CEO, SyncThink
CEO, AbleTo

By 2030, 20% of the US will be over 65. Boomers represent the biggest, most lucrative MA growth segment.

Co-Founder and CEO, Clover Health
CEO, Alignment Healthcare
Former President of Government Business, Anthem/BCBSM, Senior Adviser, Oliver Wyman
Partner, Health and Life Sciences, Oliver Wyman

HMSA and Navvis Partner to Improve the Health of the People of Hawaii

Navvis and HMSA are ending fee-for-service and moving primary care physicians to value-based payments.

Executive Officer and President, Navvis
President and CEO, Hawaii Medical Service Association
Editor, Health and Life Sciences, Oliver Wyman

Mount Sinai's partnership philosophy to reduce consumer burden.

CFO, Mount Sinai Health System
Partner, Health and Life Sciences, Oliver Wyman

What it's like to be the only female leader in the room, and how digital innovation is advancing SDoH.

Professor of Medicine and Population Health, The University of Texas at Austin Dell Medical School
Managing Partner, Americas, Oliver Wyman

Insights in your inbox


The future of hospitals' Apple Health integration.

President, CareJourney
Partner, Health and Life Sciences, Oliver Wyman

High-tech versus high-touch and how to measure innovation's ROI.

Chief Medical Officer, Livongo

Blockchain 101, what the industry can learn from consumers’ health hacks, and the key to successful incumbent-innovator partnerships. All in 23 minutes.

SVP and Chief Innovation Officer, Humana

What healthcare can learn from banking's consumer missteps.

CEO, Oliver Wyman

Aledade's deal with UnitedHealthcare, and why independent docs are key to market transformation.

Founder and CEO, Aledade

Insights in your inbox